Catalytic Converters
& Chronic Fatigue Syndrome

The following document is from a worn photocopy provided to us by Walter Covert.
Letter to the Editor from Letter for Doctors July 1991

Editor:

With particular interest I read the article by Drs. Judyth Reichenberg-Ullman and Robert Ullman on Chronic Fatigue Syndrome (TLfD January '91 p.28-29). Also, I saw around Easter, Larry King's CNN show on chronic fatigue syndrome.

We have shown over the last years that there is a dramatic increase of the adeno- and alveolar lung cancer incidence in those countries where catalytic platinum converters are mounted into the exhaust tubes of automobiles.

Every automobile loses more than 5X10 (to the 13th) atoms of platinum per mile, into the atmosphere. Upon inhalation, platinum atoms may be energized to become most dangerous radicals.

The voltage of the tension field of lung alveolar cell membranes is in the range of 90KV/cm: enough to render the platinum atom a radical. We have now published an extensive monograph on the problem. (1)

A few weeks ago the French-Belgian press described the catalytic converter catastrophe as of 'a Chernobyl dimension.'

In addition to the emitting of platinum and of harmful EMF energies by the platinum catalyst, the mufflers of such automobiles emit a series of toxic gases produced by the converter (not by diesels or by gasoline motors without converters).

These gases are:

In the presence of heat MTBE and ZDTP would react and form potentially extremely toxic agents like phosphoric acid esters (nerve gas, anti- acetylcholine factors.)

We are indebted to several department directors with Volkswagon, Mercedes- Benz, Citroen and Renault who have supplied me with the necessary information.

Chronic Fatigue Syndrome is primarily observed in the USA, in Japan (where it is called "man killing syndrome"), in Taiwan, in certain congested city areas of Australia, and more recently, in Germany and in Switzerland where catalysts in automobiles were mounted only recently. Again, we see a correlation between the disease epidemiology and the distribution of catalysts in automobiles.

Since chronic fatigue syndrome is - in the USA - only observed since about 4 years ago it is very likely that the reaction product out of MTBE and ZDTP, may be together with H2S, accounts for the major causative factor of CFS.

MTBE and ZDTP were increased as additives to fuel and about 6 or 7 years ago in order to improve the specific motor efficiency and to redress the "float consumption."

The recovery of the patients, once they stay at home for a longer time also indicates that there might be an aerogeni factor which account for CFS.

Dr. Hans A. Nieper, Past-President
The German Society of Oncology
Department of Medicine
References

1. Der Steuerbegomatigte Lungenkrebe (Lung Cancer Favorized by Tax Reduction), 2nd Edition, 36 pages.

2. Telemoustique TV Journal March 29 and April 5, 1991. Brussels, Belgium

3. Raum und Zeit (Space and Time), publisher. (date not readable)

This material can be obtained inside the USA.


Click here to view the Nieper Archives

You can contact them at drbrewer@mwt.net
Lillian Hanke
Librarian

Brewer Science Library
325 N. Central Ave.
Richland Center, WI 53581
Ph. 608-647-6513 Fax 608-647-6797